Rush University Medical Center

Research CenterTreats Aortic, Mitral, and Tricuspid valves

AI Description

Rush University Medical Center provides heart valve evaluation and treatment through a multidisciplinary team of interventional cardiologists, cardiac surgeons, imaging cardiologists and other specialists. Care includes open valve repair or replacement and catheter-based procedures such as TAVR for aortic stenosis, TEER or transcatheter replacement for mitral regurgitation, and treatments for tricuspid regurgitation.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

1653 West Congress Parkway
Chicago, IL 60612

Clinical Trials

Active, not recruiting

SUMMIT

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Public sites
71
Start date
Jun 15, 2018
Active, not recruiting

EARLY TAVR

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Public sites
66
Start date
Jul 12, 2017
Active, not recruiting

P3

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Public sites
62
Start date
Mar 1, 2016
Recruiting

PROGRESS

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Public sites
57
Start date
Oct 12, 2021
Recruiting

ENCIRCLE

The ENCIRCLE Trial

Public sites
52
Start date
Nov 12, 2020
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017

Nearby Centers